The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...
The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and ...
The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...
UnitedHealth (UNH) and Cigna (CI) are under pressure as the FTC looks to resume a lawsuit against their PBMs. Read more here.
The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...
Created in 1914, the FTC is tasked with stopping unfair trade practices — particularly those by big corporations that use ...
The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the ...
A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings ...
Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...
The FTC sued the three PBMs in September, accusing them of running an illicit drug rebate system that artificially raised the prices of insulin products.
The FTC in September sued the three companies, which it says together administer 80% of all prescriptions in the U.S., accusing them of unfairly limiting access to insulin drugs with lower list ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback